Fig. 1.

Rates of biochemical recurrence (BCR)-free survival rates forin men who underwentreceived RARP or LRP. (a) all patients, (b) the D’Amico low--risk groups, (c) intermediate-risk groups, (d) high-risk groups. The rate of BCR-free survival was significantly higher among men who received RARP compared with that reported in patients who received LRP (A: p = 0.029), especially for those classified as D'Amico high-risk patients (D: p = 0.024). There were no significant differences in the number of patients classified as D'Amico low- or intermediate-risk patients (B: p = 0.166, C: p = 0.174). LRP, laparoscopic radical prostatectomy; RARP, robot-assisted radical prostatectomy.